Artikel
Why early, big-picture planning is key to execution across the CGT lifecycle
For cell and gene therapies, the solution for the challenge you have today may create another challenge tomorrow. Early decisions around clinical development, manufacturing, regulatory strategy, and evidence generation can affect commercialization years later. See how successful manufacturers can take a cross-functional approach across the lifecycle to prevent obstacles before they occur.
